Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23968914 | 0.88 | ESR1 (0.36) | MAPTPKMALDH1A1GAAESR1 | |
| SCHEMBL23969054 | 0.86 | MAPT (0.33) | MAPTPKMALDH1A1GAAESR2 | |
| SCHEMBL21917303 | 0.84 | ALDH1A1 (0.33) | MAPTPKMALDH1A1GAAESR1 | |
| SCHEMBL21917092 | 0.84 | ALDH1A1 (0.33) | MAPTPKMALDH1A1GAAESR1 | |
| SCHEMBL21917430 | 0.84 | CNR1 (0.38) | MAPTPKMALDH1A1GAAESR2 | |
| SCHEMBL23968949 | 0.84 | CNR1 (0.38) | MAPTPKMALDH1A1GAAESR2 | |
| SCHEMBL23968939 | 0.83 | CYP11B1 (0.39) | MAPTPKMALDH1A1GAACYP11B1 | |
| SCHEMBL21917270 | 0.82 | XDH (0.40) | MAPTPKMALDH1A1GAAESR1 | |
| SCHEMBL23968846 | 0.82 | CYP11B2 (0.43) | CYP11B1CYP11B2 | |
| SCHEMBL21917287 | 0.82 | CYP11B2 (0.43) | CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | MAPT 1908/4885PKM 2603/4885ALDH1A1 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.